Found: 7
Select item for more details and to access through your institution.
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial.
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0307268
- By:
- Publication type:
- Article
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2022, v. 13, n. 2, p. 858, doi. 10.1002/jcsm.12934
- By:
- Publication type:
- Article
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia—Analyses from the LACE randomised controlled trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0294330
- By:
- Publication type:
- Article
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0292402
- By:
- Publication type:
- Article
Recruitment strategies for sarcopenia trials: lessons from the LACE randomized controlled trial.
- Published in:
- JCSM Rapid Communications, 2021, v. 4, n. 2, p. 93, doi. 10.1002/rco2.38
- By:
- Publication type:
- Article
Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT.
- Published in:
- Efficacy & Mechanism Evaluation (EME), 2022, v. 9, n. 8, p. v, doi. 10.3310/LLBX6901
- By:
- Publication type:
- Article
Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article